Market Research Report
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
|Published by||Frost & Sullivan||Product code||296265|
|Published||Content info||58 Pages
Delivery time: 1-2 business days
|Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry|
|Published: February 12, 2014||Content info: 58 Pages||
This publication has been discontinued on January 8, 2020.
Vigilance and Equanimity are the Needs of the Hour
This study for the private equity and venture capital trends in the global pharmaceutical and biotechnology industry analyzes the various deals in the industry. The deals are analyzed based on number and average value. The trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross border deals and also keeps into account various deal multiples such as deal value and investment rounds. The distribution of deals across key therapeutic areas has been dealt to understand the focus of investors and to highlight the key therapeutic areas in the near future. The analysis also includes geography-wise interest of buyers in regions across other geographies in terms both deal value and volume.